Profile picture

Hadine Joffe, M.D.

Professor of Psychiatry, Beth Israel Deaconess Medical Center
Head of the Department of Psychiatry at Beth Israel Deaconess Medical Center, Beth Israel Deaconess Medical Center
Harvard Title

Paula A. Johnson Professor of Psychiatry in the Field of Women’s Health 

Administrative and Hospital Titles

Chair and Psychiatrist-in Chief of the Department of Psychiatry at Beth Israel Deaconess Medical Center

Other Affiliations

Dana-Farber/Harvard Cancer Center Breast Cancer Program, Psychosocial Oncology and Palliative Care at Dana-Farber Cancer Institute 

Address

Beth Israel Deaconess Medical Center
Department of Psychiatry
330 Brookline Ave
Boston, MA 02215

Publications View
Disruption of Sleep Continuity During the Perimenopause: Associations with Female Reproductive Hormone Profiles.
Authors: Coborn J, de Wit A, Crawford S, Nathan M, Rahman S, Finkelstein L, Wiley A, Joffe H.
J Clin Endocrinol Metab
View full abstract on Pubmed
Changes in serum endogenous estrogen concentrations are mediators of the effect of low-dose oral estradiol on vasomotor symptoms.
Authors: Ensrud KE, Larson JC, Guthrie KA, Crandall CJ, LaCroix AZ, Reed SD, Bhasin S, Mitchell CM, Joffe H.
Menopause
View full abstract on Pubmed
The longitudinal relation of inflammation to incidence of vasomotor symptoms.
Authors: Gold EB, Xing G, Avis NE, Harlow S, Joffe H, Matthews K, Pavlovic JM, Thurston RC, Waetjen E.
Menopause
View full abstract on Pubmed
Preface to theme issue on women's health and clinical trials.
Authors: Spagnolo PA, Lorell BH, Joffe H.
Contemp Clin Trials
View full abstract on Pubmed
Sleep Fragmentation and Estradiol Suppression Decrease Fat Oxidation in Premenopausal Women.
Authors: Grant LK, Coborn JE, Cohn A, Nathan MD, Scheer FAJL, Klerman EB, Kaiser UB, Harder J, Abramson M, Elguenaoui E, Russell JA, Wiley A, Rahman SA, Joffe H.
J Clin Endocrinol Metab
View full abstract on Pubmed
Risk of high depressive symptoms after the final menstrual period: the Study of Women's Health Across the Nation (SWAN).
Authors: Kravitz HM, Colvin AB, Avis NE, Joffe H, Chen Y, Bromberger JT.
Menopause
View full abstract on Pubmed
NAMS 2021 Utian Translational Science SymposiumSeptember 2021, Washington, DCCharting the path to health in midlife and beyond: the biology and practice of wellness.
Authors: Santoro NF, Coons HL, El Khoudary SR, Epperson CN, Holt-Lunstad J, Joffe H, Lindsey SH, Marlatt KL, Montella P, Richard-Davis G, Rockette-Wagner B, Salive ME, Stuenkel C, Thurston RC, Woods N, Wyatt H.
Menopause
View full abstract on Pubmed
A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trial.
Authors: Bove R, Anderson A, Rowles W, Rankin KA, Hills NK, Carleton M, Cooper J, Cree BAC, Gelfand JM, Graves JS, Henry RG, Krysko KM, Rush G, Zamvil SS, Joffe H, Chan JR, Green AJ.
Mult Scler Relat Disord
View full abstract on Pubmed
Enrollment of female participants in United States drug and device phase 1-3 clinical trials between 2016 and 2019.
Authors: Sosinsky AZ, Rich-Edwards JW, Wiley A, Wright K, Spagnolo PA, Joffe H.
Contemp Clin Trials
View full abstract on Pubmed
A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women.
Authors: Rahman SA, Nathan MD, Wiley A, Crawford S, Cohn AY, Harder JA, Grant LK, Erickson A, Srivastava A, McCormick K, Bertisch SM, Winkelman JW, Joffe H.
Sleep
View full abstract on Pubmed